The latest price target for Exelixis (NASDAQ:EXEL) was reported by UBS on January 28, 2025. The analyst firm set a price target for $34.00 expecting EXEL to rise to within 12 months (a possible 4.62% upside). 49 analyst firms have reported ratings in the last year.

The latest analyst rating for Exelixis (NASDAQ:EXEL) was provided by UBS, and Exelixis maintained their neutral rating.

The last upgrade for Exelixis Inc happened on January 27, 2025 when Morgan Stanley raised their price target to $40. Morgan Stanley previously had an equal-weight for Exelixis Inc.

The last downgrade for Exelixis Inc happened on January 24, 2025 when Oppenheimer changed their price target from $41 to $33 for Exelixis Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Exelixis, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Exelixis was filed on January 28, 2025 so you should expect the next rating to be made available sometime around January 28, 2026.

While ratings are subjective and will change, the latest Exelixis (EXEL) rating was a maintained with a price target of $30.00 to $34.00. The current price Exelixis (EXEL) is trading at is $32.50, which is within the analyst’s predicted range.